Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Prolonged Grief Disorder

ClinicalTrials.gov lists 39 trials for Prolonged Grief Disorder or a narrower condition beneath it.

MeSH D000090382 Mental Disorders F03
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Phase 1 Phase 1 3 Phase 2/3 Phase 2/3 1 Phase 4 Phase 4 1 Not applicable Not applicable 31 Observational Observational 3 Phase 1 Phase 1 3 Phase 2/3 Phase 2/3 1 Phase 4 Phase 4 1 Not applicable Not applicable 31 Observational Observational 3

Trials per phase (log scale)

39 of the 39 trials are tagged with Prolonged Grief Disorder itself; the rest are tagged with a narrower condition beneath it.

Get the Prolonged Grief Disorder report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Prolonged Grief Disorder trials start? (16)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year. 1 trial is registered to start in 2027 or later, and not listed here.

Trials over time, by phase

  • Phase 1
  • Phase 4
  • Not applicable
  • Observational

Top of scale: 9

2000: 1 trials (Not applicable 1) 2007: 1 trials (Phase 1 1) 2009: 1 trials (Phase 1 1) 2010: 1 trials (Observational 1) 2013: 1 trials (Not applicable 1) 2014: 1 trials (Not applicable 1) 2015: 1 trials (Not applicable 1) 2018: 1 trials (Observational 1) 2019: 1 trials (Not applicable 1) 2020: 1 trials (Not applicable 1) 2021: 8 trials (Observational 1, Not applicable 6, Phase 4 1) 2022: 2 trials (Not applicable 2) 2023: 2 trials (Not applicable 2) 2024: 2 trials (Not applicable 2) 2025: 9 trials (Not applicable 9)

Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 5
2025 9
2024 2
2023 2
2022 2
2021 8
2020 1
2019 1
2018 1
2015 1

No forecast is made for this condition: it averages 4.2 trial starts a year over the five years to September, under the 5 a year the method needs.

Prediction, not a registry value: median of 23 months from start to primary completion across 11 trials still running at the 2026-10-09 snapshot; registered median of 16 months across 17 trials with a primary completion typed Actual. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Prolonged Grief Disorder trials in? (5)

Shown in this order: phase order.

Show the trials by phase as a table
Trials by phase
Phase Trials
Phase 1 3
Phase 2/3 1
Phase 4 1
Not applicable 31
Observational 3

How many Prolonged Grief Disorder trials are recruiting? (8)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Not yet recruiting 4
Recruiting 8
Enrolling by invitation 1
Active, not recruiting 2
Completed 15

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Which drugs are being tested for Prolonged Grief Disorder? (1)

Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.

Drugs tested
Drug Trials
DEXMEDETOMIDINE 1

Interventions as named in the registry (6)

Shown in this order: most trials first.

Interventions as named in the registry
Drug Trials
IM Oxytocin 1
Standard Treatment 1
IM naltrexone 1
Psilocybin 25 mg 1
Treatment As Usual 1

These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.

Which serious adverse events do Prolonged Grief Disorder trials report? (1)

Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.

Serious adverse events in this condition's trials
Adverse event Subjects affected Trials
Serious Adverse Event 1 1

Which publications cover Prolonged Grief Disorder? (8)

Shown in this order: major-topic papers first, then newest, then most linked to trials.

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: lead sponsors, prevalence, rare-disease identity, and sub-conditions in mesh.

Browse all condition evidence pages